HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hypothalamus-pituitary-thyroid axis disruption in rats with breast cancer is related to an altered endogenous oxytocin/insulin-regulated aminopeptidase (IRAP) system.

Abstract
Associations of breast cancer with diseases of the thyroid have been repeatedly reported, but the mechanism underlying this association remains to be elucidated. It has been reported that oxytocin (OXT) attenuates the thyroid-stimulating hormone (TSH) release in response to thyrotrophin-releasing hormone (TRH) and decreased plasma levels of TSH as well as the thyroid hormones by an effect mediated by the central nervous system. Oxytocinase (IRAP) is the regulatory proteolytic enzyme reported to hydrolyze OXT. Changes in IRAP activity have been reported in both human breast cancer and N-methyl-nitrosourea (NMU)-induced rat mammary tumours. Here, we measure IRAP activity fluorometrically using cystyl-β-naphthylamide as the substrate, in the hypothalamus-pituitary-thyroid axis together with the circulating levels of OXT, and its relationship with circulating levels of TSH and free thyroxine (fT4), as markers of thyroid function in control rats and rats with breast cancer induced by NMU. We found decreased thyroid function in rats with breast cancer induced by NMU, supported by the existence of lower serum circulating levels of both TSH and fT4 than their corresponding controls. Concomitantly, we found a decrease of hypothalamic IRAP activity and an increase in circulating levels of OXT. We propose that breast cancer increases OXT pituitary release by decreasing its hypothalamic catabolism through IRAP activity, probably due to the alteration of the estrogenic endocrine status. Thus, high circulating levels of OXT decreased TSH release from the pituitary, and therefore, of thyroid hormones from the thyroid, supporting the association between breast cancer and thyroid function disruption.
AuthorsMaría Pilar Carrera-González, María Jesús Ramírez-Expósito, Jose Manuel Arias de Saavedra, Rafael Sánchez-Agesta, María Dolores Mayas, Jose Manuel Martínez-Martos
JournalTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine (Tumour Biol) Vol. 32 Issue 3 Pg. 543-9 (Jun 2011) ISSN: 1423-0380 [Electronic] Netherlands
PMID21207221 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Oxytocin
  • Thyrotropin
  • Cystinyl Aminopeptidase
  • leucyl-cystinyl aminopeptidase
  • Thyroxine
Topics
  • Animals
  • Cystinyl Aminopeptidase (physiology)
  • Female
  • Hypothalamo-Hypophyseal System (physiopathology)
  • Mammary Neoplasms, Experimental (physiopathology)
  • Oxytocin (physiology)
  • Rats
  • Rats, Wistar
  • Thyroid Gland (physiopathology)
  • Thyrotropin (blood)
  • Thyroxine (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: